Sanz-Ruiz Ricardo, Vázquez-Álvarez María Eugenia, Gutiérrez-Ibañes Enrique, Díez-delHoyo Felipe, Tamargo-Delpon María, García-Carreño Jorge, Soriano-Trigueros Javier, Elízaga-Corrales Jaime, Fernández-Avilés Francisco
Department of Cardiology, Instituto de Investigación Sanitaria Gregorio Marañon (IiSGM), Hospital General Universitario Gregorio Marañón, 28007 Madrid, Spain.
Faculty of Medicine, Universidad Complutense de Madrid, 28040 Madrid, Spain.
J Clin Med. 2022 Oct 30;11(21):6444. doi: 10.3390/jcm11216444.
Important breakthroughs have considerably improved the outcomes of the percutaneous treatment of valvular heart diseases during the last decades. However, calcium deposition and progressive calcification of the left-sided heart valves present a challenge with prognostic implications that have not been addressed until recently. In the case of native mitral stenosis with no surgical options, a compelling need for tackling heavily calcified valves has led to the development of novel debulking techniques and to the use of aortic balloon-expandable bioprosthesis in the mitral position. In this section of the special issue "Mitral Valve Disease: State of the Art", we will review standard approaches and indications for the treatment of native mitral stenosis; summarize these two innovative solutions and their evidence, describing both procedures in a "step-by-step" fashion; and briefly comment on future directions in this field.
在过去几十年中,重要突破显著改善了心脏瓣膜病经皮治疗的效果。然而,左侧心脏瓣膜的钙沉积和渐进性钙化带来了挑战,其预后影响直到最近才得到解决。对于没有手术选择的原发性二尖瓣狭窄病例,迫切需要处理严重钙化的瓣膜,这促使了新型减容技术的发展以及在二尖瓣位置使用主动脉球囊扩张生物假体。在本期“二尖瓣疾病:最新进展”特刊的这一部分中,我们将回顾原发性二尖瓣狭窄治疗的标准方法和适应症;总结这两种创新解决方案及其证据,以“逐步”方式描述这两种手术;并简要评论该领域的未来方向。